Association of the Triglyceride Glucose Index with All Cause and CVD Mortality in the Adults with Diabetes Aged < 65 years Without Cardiovascular Disease

Overview

Journal Sci Rep

Date 2025 Jan 21

PMID 39838034

Authors

Chang Liu

Dan Liang

Guoan Xiang

Xuanbo Zhao

Kun Xiao

Lixin Xie

Affiliations

Soon will be listed here.

Abstract

Although the triglyceride-glucose (TyG) index has been established as a valuable predictor for cardiovascular disease (CVD) and cardiovascular mortality, there is limited research exploring its association with all-cause or CVD mortality specifically in adults with diabetes aged < 65 years without cardiovascular disease. This study aimed to investigate the relationship between the TyG index and both all-cause and CVD mortality in this population within the United States. Our study recruited 1778 adults with diabetes aged < 65 years without cardiovascular disease from the National Health and Nutrition Examination Survey (NHANES) 2003-2018. Mortality outcomes were determined by linking to National Death Index (NDI) records up to December 31, 2019. Cox regression modeling was employed to examine the association between the TyG index and mortality in this population. The nonlinear relationship between the TyG index and mortality was assessed using restricted cubic splines (RCS). Additionally, subgroup analyses and interaction tests were conducted to explore potential effect modifiers. A total of 1788 participants were included in the final cohort, with an average age of 49.61 ± 0.32 years. During a median follow-up of 7.92 years, the occurrence of 150 all-cause deaths and 33 CVD-related deaths were recorded. To investigate the independent association between the TyG index and the risks of all-cause and CVD mortality, three Cox regression models were developed. In Model 1, a significant positive association was observed between the TyG index and the risk of all-cause mortality (HR 1.38, 95% CI 1.09-1.74). This association persisted in the minimally adjusted model (HR 1.44, 95% CI 1.13-1.83), which was adjusted for age, gender and race. Even after full adjustment, this positive association remained significant (HR 1.91, 95% CI 1.36-2.70). We also found that the relationship between the TyG index and all-cause mortality was linear. Subgroup analyses revealed no significant interactions between the TyG index and the stratification variables. However, we did not observe a significant association between the TyG index and CVD mortality in this population. Our results suggested that a significantly positive association between the TyG index and all-cause mortality. The positive association between the TyG index and all-cause mortality was linear. We did not observe a significant association between the TyG index and CVD mortality.

References

Wu Z, Liu L, Wang W, Cui H, Zhang Y, Xu J . Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study. Cardiovasc Diabetol. 2022; 21(1):142. PMC: 9338459. DOI: 10.1186/s12933-022-01576-8. View

Kosmas C, Bousvarou M, Kostara C, Papakonstantinou E, Salamou E, Guzman E . Insulin resistance and cardiovascular disease. J Int Med Res. 2023; 51(3):3000605231164548. PMC: 10069006. DOI: 10.1177/03000605231164548. View

Takaeko Y, Maruhashi T, Kajikawa M, Kishimoto S, Yamaji T, Harada T . Lower triglyceride levels are associated with better endothelial function. J Clin Lipidol. 2021; 15(3):500-511. DOI: 10.1016/j.jacl.2021.04.004. View

Barrot-de la Puente J, Mata-Cases M, Franch-Nadal J, Mundet-Tuduri X, Casellas A, Fernandez-Real J . Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database. Int J Clin Pract. 2015; 69(12):1486-95. PMC: 5054846. DOI: 10.1111/ijcp.12741. View

Lu Y, Chang C, Chou R, Tsai Y, Liu L, Chen L . Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. Cardiovasc Diabetol. 2021; 20(1):206. PMC: 8515653. DOI: 10.1186/s12933-021-01391-7. View

Shen J, Feng B, Fan L, Jiao Y, Li Y, Liu H . Triglyceride glucose index predicts all-cause mortality in oldest-old patients with acute coronary syndrome and diabetes mellitus. BMC Geriatr. 2023; 23(1):78. PMC: 9901061. DOI: 10.1186/s12877-023-03788-3. View

Fryar C, Ostchega Y, Hales C, Zhang G, Kruszon-Moran D . Hypertension Prevalence and Control Among Adults: United States, 2015-2016. NCHS Data Brief. 2017; (289):1-8. View

Selvi N, Nandhini S, Sakthivadivel V, Lokesh S, Srinivasan A, Sumathi S . Association of Triglyceride-Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus. Maedica (Bucur). 2021; 16(3):375-381. PMC: 8643546. DOI: 10.26574/maedica.2021.16.3.375. View

Shang J, Yu D, Cai Y, Wang Z, Zhao B, Zhao Z . The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study. Medicine (Baltimore). 2019; 98(46):e17995. PMC: 6867726. DOI: 10.1097/MD.0000000000017995. View

10.

Zhang Q, Xiao S, Jiao X, Shen Y . The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2023; 22(1):279. PMC: 10583314. DOI: 10.1186/s12933-023-02030-z. View

11.

Liu C, Liang D . The association between the triglyceride-glucose index and the risk of cardiovascular disease in US population aged ≤ 65 years with prediabetes or diabetes: a population-based study. Cardiovasc Diabetol. 2024; 23(1):168. PMC: 11092030. DOI: 10.1186/s12933-024-02261-8. View

12.

Sawaf B, Swed S, Alibrahim H, Bohsas H, Dave T, Nasif M . Triglyceride-Glucose Index as Predictor for Hypertension, CHD and STROKE Risk among Non-Diabetic Patients: A NHANES Cross-Sectional Study 2001-2020. J Epidemiol Glob Health. 2024; 14(3):1152-1166. PMC: 11442902. DOI: 10.1007/s44197-024-00269-7. View

13.

Liu C, Liang D, Xiao K, Xie L . Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024; 23(1):171. PMC: 11097545. DOI: 10.1186/s12933-024-02269-0. View

14.

Menke A, Casagrande S, Geiss L, Cowie C . Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015; 314(10):1021-9. DOI: 10.1001/jama.2015.10029. View

15.

Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L . Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022; 21(1):128. PMC: 9270811. DOI: 10.1186/s12933-022-01563-z. View

16.

Liang D, Liu C, Wang Y . The association between triglyceride-glucose index and the likelihood of cardiovascular disease in the U.S. population of older adults aged ≥ 60 years: a population-based study. Cardiovasc Diabetol. 2024; 23(1):151. PMC: 11067197. DOI: 10.1186/s12933-024-02248-5. View

17.

Gast K, Tjeerdema N, Stijnen T, Smit J, Dekkers O . Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2013; 7(12):e52036. PMC: 3532497. DOI: 10.1371/journal.pone.0052036. View

18.

Cai W, Xu J, Wu X, Chen Z, Zeng L, Song X . Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023; 22(1):138. PMC: 10262584. DOI: 10.1186/s12933-023-01864-x. View

19.

Jia G, Hill M, Sowers J . Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res. 2018; 122(4):624-638. PMC: 5819359. DOI: 10.1161/CIRCRESAHA.117.311586. View

20.

Lambie M, Bonomini M, Davies S, Accili D, Arduini A, Zammit V . Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis. Trends Endocrinol Metab. 2021; 32(9):721-730. PMC: 8893168. DOI: 10.1016/j.tem.2021.06.001. View